This project offers the tantalising possibility that plants containing drugs, such as agents to treat HIV, could be farmed on a small scale at low cost by communities that need them most.
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai Drug development
Menampilkan 21 - 40 dari 51 artikel
News that a leading manufacturer will cease making a well-known antivenom is not actually new.
A so-called "organ-on-chip" device could speed up the way drugs are developed. And it's just been named the London Design Museum's design of the year.
You may not have heard of the protein lubricin, but it's what keeps your body moving. And now it's being used to treat disease and produce new therapeutics.
We’ve heard a lot lately about superbugs – bacteria that are resistant to current antibiotics. But as the threat of superbugs continues to rise, the number of new treatments available has flatlined. This…
An ambitious project has been launched that will involve sequencing genomes of 100,000 individuals to improve our understanding of a range of diseases and – hopefully – eventually find new treatments for…
The rise of bacteria that are resistant to antibiotics is a growing worry and threatens to put healthcare back to the early 20th century. Such resistance to drugs was inevitable, because bacteria evolve…
Disease can affect any person, rich or poor. While your bank balance can’t really protect you from getting sick, it could potentially buy you – and many other patients – access to a better treatment for…
Development of new drugs for treatment of disease is an expensive, time-consuming and labour-intensive effort for both pharmaceutical companies and academics. For the past 15 years, “cost per approval…
Foundation essay: This article is part of a series marking the launch of The Conversation in the US. Our foundation essays are longer than our usual comment and analysis articles and take a wider look…
It can take 12 years and more than £1 billion to create a new medicine. But when we swallow a capsule, squeeze those eye drops or administer an injection, we rarely stop to think about the work that has…
The extent of the current Ebola virus outbreak in West Africa has belatedly focused the attention of non-governmental organisations, local and Western governments, and international media. What we haven’t…
Ebola virus disease typically only occurs in rural and remote areas among resource-poor populations. Until the large, recent outbreak in West Africa, cases of the illness were a rarity. So the fact that…
Researchers in the UK have created an atlas of genetic associations with metabolic molecules, providing new insights into…
The National Institute for Health and Care Excellence (NICE) has published new draft proposals laying out major changes to the way it assesses whether new medicines offer value for money for the NHS. These…
Developing new drugs is hard and expensive. The lengthy process from initial discovery to the market is some times compared…
New research has revealed that venom can be stored for up to 80 years without losing any of its biological properties. Researchers…
Daily jabs of insulin are a painful reality for many with diabetes. That may change if researchers who have successfully…
It has been described as a historical “turning point” in Alzheimer’s treatment - the first time a chemical has been found that can halt the death of brain tissue in a neurodegenerative disease, and could…
While scientists develop new drugs to treat a multitude of conditions, nanotechnology is pushing the boundaries of how we deliver them to patients - targeting delivery to cancer cells and giving a drug…
Kontributor teratas
-
Prof. Institute for Molecular Bioscience, The University of Queensland
-
Professor of Neuroscience, Lancaster University
-
Associate Professor of History, University of Wollongong
-
Associate professor, UNSW
-
Biostatistician, University of Melbourne
-
Senior Lecturer Biostatistics and Data Management, The University of Queensland
-
Associate Professor of Biostatistics, Murdoch Children's Research Institute
-
Lyn Gilbert adalah Sahabat The Conversation.
Clinical Professor in Medicine and Infectious Diseases, University of Sydney
-
Professor of Bioethics & Medicine, Sydney Health Ethics, University of Sydney
-
Emeritus Professor of Medical Ethics, The University of Queensland
-
Associate professor, University of Melbourne
-
Adjunct Fellow, School of Law & School of Medicine, Western Sydney University
-
Executive General Manager Commercialisation and Research Contracts, Baker Heart and Diabetes Institute
-
Senior Fellow at Research for Social Change, University of Wollongong
-
Distinguished Writer In Residence, Arthur Carter Journalism Institute, New York University
